UK Health Secretary Wes Streeting Refutes Trump’s Paracetamol and Autism Claims
In a recent interview on ITV’s Lorraine, UK Health Secretary Wes Streeting firmly rejected President Donald Trump’s assertion that taking paracetamol (known as acetaminophen in the U.S.) during pregnancy is linked to autism in children. Streeting emphasized, “I trust doctors over President Trump, frankly, on this,” highlighting the importance of relying on scientific evidence and medical professionals for health guidance.
President Trump’s comments, made during a White House event, suggested that the use of paracetamol during pregnancy could contribute to a rise in autism cases. He recommended that pregnant women avoid the medication unless absolutely necessary, advising them to “tough it out” in cases of mild pain.
Scientific Studies and Expert Opinions
Streeting referenced a comprehensive study conducted in Sweden in 2024, which involved 2.4 million children and found no evidence linking prenatal paracetamol exposure to autism. This large-scale research contradicts Trump’s claims and underscores the importance of basing health decisions on robust scientific data.
Supporting Streeting’s stance, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the National Health Service (NHS) have affirmed that paracetamol is a safe and effective pain relief option during pregnancy when used as directed. These organizations stress that the benefits of managing pain and fever during pregnancy outweigh any unsubstantiated risks.
Furthermore, autism advocacy groups, including the National Autistic Society, have condemned Trump’s remarks as misleading and potentially harmful. They caution that spreading misinformation about autism can contribute to stigma and divert attention from the real challenges faced by individuals on the autism spectrum.
Global Health Community’s Response
The global health community has largely dismissed Trump’s claims. The World Health Organization (WHO) and other international health bodies have reiterated that there is no credible evidence linking paracetamol use during pregnancy to autism. They emphasize the need for public health messages to be grounded in scientific research to ensure the well-being of populations.
Conclusion
Health Secretary Wes Streeting’s response serves as a reminder of the importance of relying on evidence-based medicine and expert advice, especially when it comes to public health matters. As the debate over paracetamol use during pregnancy continues, it is crucial for individuals to consult with healthcare professionals and consider the latest scientific findings before making health decisions.